Skip to main content

Advertisement

Log in

Small bowel bacterial overgrowth: A negative factor in gut adaptation in pediatric SBS

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Small bowel bacterial overgrowth (SBBO) is common in infants and children with short bowel syndrome (SBS). Its occurrence is due to alterations in anatomy, motility, and secretion, which promote the abnormal growth of bacteria. SBBO is associated with significant clinical problems, including prolonged dependence on parenteral nutrition, liver injury, and malabsorption. A major clinical challenge is in making the correct diagnosis of bacterial overgrowth. Management of this disorder is still poorly understood and should be evaluated adequately. This review addresses the current understanding of bacteria in the intestines and issues related to bacterial overgrowth in pediatric SBS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Buchman AL, Scolapio J, Fryer J: AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology, 2003, 124:1111–1134.

    PubMed  Google Scholar 

  2. Schwartz MZ, Maeda K: Short bowel syndrome in infants and children. Pediatr Clin North Am 1985, 32:1265–1279.

    PubMed  CAS  Google Scholar 

  3. Wales PW, de Silva N, Kim JH, et al.: Neonatal short bowel syndrome: a cohort study. J Pediatr Surg 2005, 40:755–762.

    Article  PubMed  Google Scholar 

  4. O’Keefe SJ, Buchman AL, Fishbein TM, et al.: Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol 2006, 4:6–10.

    Article  PubMed  Google Scholar 

  5. Wales PW, de Silva N, Kim J, et al.: Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. J Pediatr Surg 2004, 39:690–695.

    Article  PubMed  Google Scholar 

  6. Kocoshis SA: Short bowel and long life: no longer mutually exclusive. J Pediatr 2004, 145:147–148.

    PubMed  Google Scholar 

  7. Sondheimer JM, Cadnapaphornchai M, Sontag M, Zerbe GO: Predicting the duration of dependence on parenteral nutrition after neonatal intestinal resection. J Pediatr 1998, 132:80–84.

    Article  PubMed  CAS  Google Scholar 

  8. Javid PJ, Collier S, Richardson D, et al.: The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants. J Pediatr Surg 2005, 40:1015–1018.

    Article  PubMed  Google Scholar 

  9. Andorsky DJ, Lund DP, Lillehei CW, et al.: Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 2001, 139:27–33.

    Article  PubMed  CAS  Google Scholar 

  10. Richards DM, Irving MH: Cost-utility analysis of home parenteral nutrition. Br J Surg 1996, 83:1226–1229.

    Article  PubMed  CAS  Google Scholar 

  11. Richards DM, Irving MH: Assessing the quality of life of patients with intestinal failure on home parenteral nutrition. Gut 1997, 40:218–222.

    PubMed  CAS  Google Scholar 

  12. Diamond IR, de Silva N, Pencharz PB, et al.: Neonatal short bowel syndrome outcomes after the establishment of the first Canadian multidisciplinary intestinal rehabilitation program: preliminary experience. J Pediatr Surg 2007, 42:806–811.

    Article  PubMed  Google Scholar 

  13. Palmer C, Bik EM, Digiulio DB, et al.: Development of the human infant intestinal microbiota. PLoS Biol 2007, 5:e177.

    Article  PubMed  CAS  Google Scholar 

  14. Mueller C, Macpherson AJ: Layers of mutualism with commensal bacteria protect us from intestinal inflammation. Gut 2006, 55:276–284.

    Article  PubMed  CAS  Google Scholar 

  15. Macpherson AJ, Harris NL: Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004, 4:478–485.

    Article  PubMed  CAS  Google Scholar 

  16. Dibaise JK, Young RJ, Vanderhoof JA: Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol 2006, 4:11–20.

    Article  PubMed  Google Scholar 

  17. Vanderhoof JA, Young RJ, Thompson JS: New and emerging therapies for short bowel syndrome in children. Paediatr Drugs 2003, 5:525–531.

    Article  PubMed  Google Scholar 

  18. Eamonn MMQ, Rodrigo Q: Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 2006, 130:S78–S90.

    Article  CAS  Google Scholar 

  19. Backhed F, Ding H, Wang T, et al.: The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004, 101:15718–15723.

    Article  PubMed  CAS  Google Scholar 

  20. Stappenbeck TS, Hooper LV, Gordon JI: Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 2002, 99:15451–15455.

    Article  PubMed  CAS  Google Scholar 

  21. Albert MJ, Mathan VI, Baker SJ: Vitamin B12 synthesis by human small intestinal bacteria. Nature 1980, 283:781–782.

    Article  PubMed  CAS  Google Scholar 

  22. Ramakrishna BS: The normal bacterial flora of the human intestine and its regulation. J Clin Gastroenterol 2007, 41(Suppl 1):S2–S6.

    Article  Google Scholar 

  23. Kelly D, King T, Aminov R: Importance of microbial colonization of the gut in early life to the development of immunity. Mutat Res 2007, 622:58–69.

    PubMed  CAS  Google Scholar 

  24. Kaufman SS, Loseke CA, Lupo JV, et al.: Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome. J Pediatr 1997, 131:356–361.

    Article  PubMed  CAS  Google Scholar 

  25. Vanderhoof JA, Young RJ, Murray N, Kaufman SS: Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr 1998, 27:155–160.

    Article  PubMed  CAS  Google Scholar 

  26. Dellert SF, Nowicki MJ, Farrell MK, et al.: The 13C-xylose breath test for the diagnosis of small bowel bacterial overgrowth in children. J Pediatr Gastroenterol Nutr 1997, 25:153–158.

    Article  PubMed  CAS  Google Scholar 

  27. Stotzer PO, Kilander AF: Comparison of the 1-gram (14)C-D-xylose breath test and the 50-gram hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth. Digestion 2000, 61:165–171.

    Article  PubMed  CAS  Google Scholar 

  28. Swidsinski A, Weber J, Loening-Baucke V, et al.: Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005, 43:3380–3389.

    Article  PubMed  Google Scholar 

  29. Swidsinski A, Loening-Baucke V, Lochs H, Hale LP: Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J Gastroenterol 2005, 11:1131–1140.

    PubMed  Google Scholar 

  30. Romagnuolo J, Schiller D, Bailey RJ: Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol 2002, 97:1113–1126.

    Article  PubMed  Google Scholar 

  31. Perman JA, Modler S, Barr RG, Rosenthal P: Fasting breath hydrogen concentration: normal values and clinical application. Gastroenterology 1984, 87:1358–1363.

    PubMed  CAS  Google Scholar 

  32. Riordan SM, McIver CJ, Walker BM, et al.: The lactulose breath hydrogen test and small intestinal bacterial over-growth. Am J Gastroenterol 1996, 91:1795–1803.

    PubMed  CAS  Google Scholar 

  33. Bardhan PK, Feger A, Kogon M, et al.: Urinary choloyl-PABA excretion in diagnosing small intestinal bacterial overgrowth: evaluation of a new noninvasive method. Dig Dis Sci 2000, 45:474–479.

    Article  PubMed  CAS  Google Scholar 

  34. Riepe SP, Goldstein J, Alpers DH: Effect of secreted Bacteroides proteases on human intestinal brush border hydrolases. J Clin Invest 1980, 66:314–322.

    Article  PubMed  CAS  Google Scholar 

  35. Bala L, Ghoshal UC, Ghoshal U, et al.: Malabsorption syndrome with and without small intestinal bacterial overgrowth: a study on upper-gut aspirate using 1H NMR spectroscopy. Magn Reson Med 2006, 56:738–744.

    Article  PubMed  Google Scholar 

  36. Oumi M, Yamamoto T: A scanning electron microscope study on the effects of different bile salts on the epithelial lining of jejunal mucosa. Med Electron Microsc 2000, 33:11–15.

    Article  PubMed  CAS  Google Scholar 

  37. Soler Palacin P, Garzón Lorenzo P, Castilla Fernández Y, et al.: D-lactic acidosis in an 11-year-old patient with short bowel syndrome [in Spanish]. An Pediatr (Barc) 2006, 64:385–387.

    Article  CAS  Google Scholar 

  38. Puwanant M, Mo-Suwan L, Patrapinyokul S: Recurrent D-lactic acidosis in a child with short bowel syndrome. Asia Pac J Clin Nutr 2005, 14:195–198.

    PubMed  Google Scholar 

  39. Petersen C: D-lactic acidosis. Nutr Clin Pract 2005, 20:634–645.

    PubMed  Google Scholar 

  40. Bolder U, Ton-Nu HT, Schteingart CD, et al.: Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology 1997, 112:214–225.

    Article  PubMed  CAS  Google Scholar 

  41. O’Brien DP, Nelson LA, Kemp CJ, et al.: Intestinal permeability and bacterial translocation are uncoupled after small bowel resection. J Pediatr Surg 2002, 37:390–394.

    Article  PubMed  Google Scholar 

  42. Schimpl G, Feierl G, Linni K, et al.: Bacterial translocation in short-bowel syndrome in rats. Eur J Pediatr Surg 1999, 9:224–227.

    PubMed  CAS  Google Scholar 

  43. D’Antiga L, Dhawan A, Davenport M, et al.: Intestinal absorption and permeability in paediatric short-bowel syndrome: a pilot study. J Pediatr Gastroenterol Nutr 1999, 29:588–593.

    Article  PubMed  CAS  Google Scholar 

  44. Yang J, Lee HR, Low K, et al.: Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS. Dig Dis Sci 2007, [Epub ahead of print].

  45. Majewski M, Reddymasu SC, Sostarich S, et al.: Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth. Am J Med Sci 2007, 333:266–270.

    Article  PubMed  Google Scholar 

  46. Attar A, Flourie B, Rambaud JC, et al.: Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology 1999, 117:794–797.

    Article  PubMed  CAS  Google Scholar 

  47. Gaon D, Garmendia C, Murrielo NO, et al.: Effect of Lactobacillus strains (L. casei and L. Acidophilus Strains cerela) on bacterial overgrowth-related chronic diarrhea. Medicina (B Aires) 2002, 62:159–163.

    Google Scholar 

  48. McCarthy J, O’Mahony L, O’Callaghan L, et al.: Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003, 52:975–980.

    Article  PubMed  CAS  Google Scholar 

  49. Kim HB, Lee PW, Garza J, et al.: Serial transverse enteroplasty for short bowel syndrome: a case report. J Pediatr Surg 2003, 38:881–885.

    Article  PubMed  Google Scholar 

  50. Kim HB, Fauza D, Garza J, et al.: Serial transverse enteroplasty (STEP): A novel bowel lengthening procedure. J Pediatr Surg 2003, 38:425–429.

    Article  PubMed  Google Scholar 

  51. Bianchi A: Experience with longitudinal intestinal lengthening and tailoring. Eur J Pediatr Surg 1999, 9:256–259.

    PubMed  CAS  Google Scholar 

  52. Modi BP, Javid PJ, Jaksic T, et al.: First report of the international serial transverse enteroplasty data registry: indications, efficacy, and complications. J Am Coll Surg 2007, 204:365–371.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Conrad R. Cole.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cole, C.R., Ziegler, T.R. Small bowel bacterial overgrowth: A negative factor in gut adaptation in pediatric SBS. Curr Gastroenterol Rep 9, 456–462 (2007). https://doi.org/10.1007/s11894-007-0059-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-007-0059-3

Keywords

Navigation